These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
manuscript.pdf (633.6 kB)

HIV Capsid Inhibitor Capacity of Different Isomers of Di-Pyridine Benzene and Its Alkyl and Halide Derivatives

submitted on 16.10.2019, 19:06 and posted on 21.10.2019, 20:54 by Nilanjana Biswas, Sangita Ghosh, Arijit Bag
HIV-1 Capsid-A inhibitor capacity of different isomers of di-pyridine benzene and its alkyl and halide derivatives are studied systematically. It is found that p-di-pyridine o-ethyl benzene has very good inhibition constant. It is a small, cost effective organic compound and very promising as a HIV drug. It is a molecular docking based study.


Email Address of Submitting Author


Maulana Abul Kalam Azad University of Technology WB



ORCID For Submitting Author


Declaration of Conflict of Interest

There is no conflict of interest.

Version Notes

It is a draft version.